Arzneimittelkriminalität ist ein ernsthaftes Problem. Das FVS sprach mit Marina Bloch, bei Bayer im Bereich der „Anti-Counterfeiting Group Medical“ tätig. Bayer engagiert sich für den Patientenschutz. Wie betroffen ist das Unternehmen selbst? Bayer ist als Life Science Unternehmen im Gesundheitsbereich auf die Forschung und Entwicklung innovativer Arzneimittel fokussiert und somit als Originalhersteller von hochwertigen Medikamenten…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |